Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. (Q35817615)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218054%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218054%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218054%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Fernando Alvarez

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218054%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

24 June 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218054%20AND%20SRC:MED&resulttype=core&format=json

Journal of Leukocyte Biology

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218054%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218054%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218054%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

743-759

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218054%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis C virus infection

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Innate and adaptive lymphoid cells in the human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Hepatitis C virus infection: when silence is deception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

A role for hepatitis C virus infection in type II cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Evolving role of pegylated interferons in metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Synthesis of a novel hepatitis C virus protein by ribosomal frameshift

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Binding of hepatitis C virus to CD81

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Hepatic T cells and liver tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

The role of immune responses in the pathogenesis of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Cytotoxic T cells and viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Analysis of a successful immune response against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Noncytolytic control of viral infections by the innate and adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Determinants of viral clearance and persistence during acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Liver damage preferentially results from CD8(+) T cells triggered by high affinity peptide antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Intrahepatic T cells in hepatitis B: viral control versus liver cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Induction of FAS ligand expression in a human hepatoblastoma cell line by HCV core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Biology of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

The role of natural killer cells in innate resistance to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Natural killer cells in antiviral defense: function and regulation by innate cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Fas-mediated cytotoxicity by freshly isolated natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Natural killer cells and viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Regulation of immune responses through inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Strategies for target cell recognition by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Human natural killer cell receptors and co-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

An activating immunoreceptor complex formed by NKG2D and DAP10

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

The biology of human natural killer-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Human Diversity in Killer Cell Inhibitory Receptor Genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Viral subversion of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Regulation of T cell function by NK cell receptors for classical MHC class I molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Regulation of the natural killer cell receptor repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Ligands for natural killer cell receptors: redundancy or specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Mouse CD1-specific NK1 T cells: development, specificity, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Liver NKT cells: an account of heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Regulation of autoimmune disease by natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Expression and function of NK cell receptors in CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

HIV's evasion of host's NK cell response and novel ways of its countering and boosting anti-HIV immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: Impairment of specific cytolytic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Multifaceted roles of MHC class I and MHC class I–like molecules in T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Cutting edge: Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

The central role of SOCS-3 in integrating the neuro-immunoendocrine interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

SOCS-3 is an insulin-induced negative regulator of insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

IL-1 beta attenuates IFN-alpha beta-induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Natural killer type 2 bias in remission of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Receptor-induced death in human natural killer cells: involvement of CD16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Production of interleukin-18 and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Liver damage by infiltrating CD8+ T cells is Fas dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197

Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304197